| Target Price | $19.38 |
| Price | $14.93 |
| Potential |
29.81%
register free of charge
|
| Number of Estimates | 17 |
|
17 Analysts have issued a price target Core Scientific 2026 .
The average Core Scientific target price is $19.38.
This is
29.81%
register free of charge
$31.50
110.98%
register free of charge
$15.15
1.47%
register free of charge
|
|
| A rating was issued by 24 analysts: 17 Analysts recommend Core Scientific to buy, 7 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Core Scientific stock has an average upside potential 2026 of
29.81%
register free of charge
|
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 510.67 | 411.36 |
| 1.65% | 19.45% | |
| EBITDA Margin | 20.68% | 23.24% |
| 6.71% | 12.40% | |
| Net Margin | -219.79% | 67.63% |
| 347.99% | 130.77% |
19 Analysts have issued a sales forecast Core Scientific 2025 . The average Core Scientific sales estimate is
This results in the following potential growth metrics:
19 Analysts have issued an Core Scientific EBITDA forecast 2025. The average Core Scientific EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
18 Core Scientific Analysts have issued a net profit forecast 2025. The average Core Scientific net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -4.39 | 0.90 |
| 575.38% | 120.50% | |
| P/E | 16.55 | |
| EV/Sales | 12.73 |
18 Analysts have issued a Core Scientific forecast for earnings per share. The average Core Scientific EPS is
This results in the following potential growth metrics and future valuations:
Core Scientific...
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Bernstein |
Locked
➜
Locked
|
Locked | Nov 03 2025 |
| Macquarie |
Locked
➜
Locked
|
Locked | Oct 31 2025 |
| Clear Street |
Locked
➜
Locked
|
Locked | Oct 28 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Oct 28 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Oct 27 2025 |
| Cantor Fitzgerald |
Locked
➜
Locked
|
Locked | Oct 24 2025 |
| Roth Capital |
Locked
➜
Locked
|
Locked | Oct 23 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Bernstein:
Locked
➜
Locked
|
Nov 03 2025 |
|
Locked
Macquarie:
Locked
➜
Locked
|
Oct 31 2025 |
|
Locked
Clear Street:
Locked
➜
Locked
|
Oct 28 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Oct 28 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Oct 27 2025 |
|
Locked
Cantor Fitzgerald:
Locked
➜
Locked
|
Oct 24 2025 |
|
Locked
Roth Capital:
Locked
➜
Locked
|
Oct 23 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


